Read + Share
Mathieu N, Hupe M, Heluwaert F, Riviere P, et al. PErsistence and Safety of Subcutaneous Infliximab 1 Year After Switch From
Intravenous Route in IBD Patients in REMission. Clin Gastroenterol Hepatol 2025;23:2597-2606.
PMID: 40398832
|
 |
|
Mathieu N, Hupe M, Heluwaert F, Riviere P, et al. PErsistence and Safety of Subcutaneous Infliximab 1 Year After Switch From
Intravenous Route in IBD Patients in REMission. Clin Gastroenterol Hepatol 2025;23:2597-2606.
PMID: 40398832
|
|
|
|